(805) 483 1185

English
Español
01 Fomat_Logo_Website-min
  • Home
  • Join a Trial
    • Join a Trial
    • Healthy Volunteers
    • Participant Stories
  • Sponsors
    • Phase I Capabilities
    • Phase II- IV Capabilities
    • Diversity
  • About Us
    • About Us
    • Our Investigators
    • Careers
    • Diversity
  • Resources
    • Company Updates
    • Blogs & Updates
    • Events and Conferences
  • Contact FOMAT

Home » vaccine

Posts tagged: vaccine

Nicotine vaccine

Breakthrough in Designing a Better Salmonella Vaccine

February 5, 2024
by Beatriz Morales

UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing a more effective and safe ...

Read More
0
Coronavirus structural morphology

FOMAT Medical Research testing promising antibody cocktail ‘REGN-COV2’ to treat, prevent COVID-19

August 31, 2020
by Beatriz Morales

FOMAT Medical Research testing promising antibody cocktail ‘REGN-COV2’ to treat, prevent COVID-19 An antibody cocktail called REGN-COV2 designed to treat and prevent ...

Read More
0
Novavax

Novavax Secures $1.6 Billion from U.S. Government for COVID-19 Vaccine Program

July 7, 2020
by Beatriz Morales

With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate, NVX‑CoV2373. Gaithersburg ...

Read More
0
Race to COVID-19 Vaccine

Milken Institute Teams with First Person to Explain the Race to a COVID-19 Vaccine

June 15, 2020
by Beatriz Morales

WASHINGTON--(BUSINESS WIRE)-- The Milken Institute, the nonprofit, nonpartisan think tank, and First Person, a San Francisco design and storytelling company, together tell the urgent story of the global race for a COVID-19 vaccine in a newly released ...

Read More
0
covid 19

Johnson & Johnson: Clinical study of potential coronavirus vaccine could start by end of year

April 16, 2020
by Beatriz Morales

Johnson & Johnson (NYSE:JNJ) said today that its Janssen Pharmaceutical Cos. has forged a partnership with the Beth Israel Deaconess Medical Center (BIDMC) to support coronavirus vaccine development. Janssen and the virology lab led by Dr. Dan B ...

Read More
0
coronavirus vaccine

How is coronavirus vaccine development going in the U.S.?

April 10, 2020
by Beatriz Morales

Researchers in Pittsburgh and Boston are moving forward with research into two separate  coronavirus vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicin ...

Read More
0
doctor-preparing-medical-vaccine

A phase 3 study for chikungunya vaccine after passing midstage test

November 7, 2018
by Beatriz Morales

The chikungunya vaccine, known as MV-CHIK, hit its primary goal in the phase 2 trial, and Themis is now eyeing a move into phase 3. The company based its chikungunya shot on its measles vector platform, licensed from Institut Pasteur. ...

Read More
0
Nicotine vaccine

Breakthrough in Designing a Better Salmonella Vaccine

October 3, 2018
by Beatriz Morales

UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing a more effective and safe ...

Read More
0
ChAd3 vaccine

The top 5 vaccine companies by 2017 revenue

August 3, 2018
by Beatriz Morales

Even in an industry dominated by a few huge companies, disruption happens sometimes—and 2017 was one of those times. GlaxoSmithKline surpassed Merck to top the vaccine industry by sales, generating $7 billion compared to Merck's $6.5 billion. It s ...

Read More
0
Plasmodium antibodies

Research Suggests New Vaccine Candidates for Malaria

July 11, 2018
by Beatriz Morales

Researchers have shown that higher levels of Plasmodium antibodies are protective against severe malaria in children living in Papua New Guinea. Children who have higher levels of antibodies to a specific short amino acid sequence in the malaria para ...

Read More
0
  • 1
  • 2
  • Next
  • Last

Contact Us

    Upcoming Events

    ASCO

    May 30 - June 3rd, 2025

    Chicago, IL

    Global SCRS

    Sep 29 - Oct 1, 2025

    Orlando, FL

    AAO 2025​

    Oct 18-20, 2025​

    Orlando, FL

    Full Event List
    • Review us on Google
    • Review us on Yelp

    Conditions & Theraputic Areas

    Join a Trial

    Healthy Volunteers

    Sponsors

    Phase I Capabilities

    Phase II & III Capabilities

    Diversity

    About Us

    Careers

    Investigators

    Contact Us

    • Review us on Google
    • Review us on Yelp

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: volunteers@fomatmedical.com
    General Information: info@fomatmedical.com

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: volunteers@fomatmedical.com
    General Information: info@fomatmedical.com
    • Review us on Google
    • Review us on Yelp
    Proud Partner of hyperCORE
    Facebook Linkedin Instagram
    Shopping Basket
    We use cookies to ensure the best possible experience on our website. By continuing to use this site, we will assume that you are happy with itAcceptPrivacy policy